Alpha-Tocopherol (Vitamin E) — Hermetica Encyclopedia
Compound · Marine-Derived

Alpha-Tocopherol (Vitamin E) (Dunaliella tertiolecta)

Preliminary EvidenceCompound

Hermetica Superfood Encyclopedia

The Short Answer

Alpha-tocopherol from Dunaliella tertiolecta is a lipid-soluble antioxidant that neutralizes reactive oxygen species (ROS) through hydrogen atom transfer (HAT) and single electron transfer (SET) mechanisms, directly quenching lipid peroxyl radicals and protecting polyunsaturated fatty acid membranes from oxidative degradation. Production studies show D. tertiolecta can accumulate up to approximately 1.90 mg alpha-tocopherol per gram dry weight under optimized high-density, light-limited batch cultivation, though no human clinical trials have yet characterized its efficacy or bioavailability as a dietary supplement.

PubMed Studies
7
Validated Benefits
Synergy Pairings
At a Glance
CategoryCompound
GroupMarine-Derived
Evidence LevelPreliminary
Primary Keywordalpha-tocopherol Dunaliella tertiolecta
Alpha-Tocopherol / Vitamin E close-up macro showing natural texture and detail — rich in stress, energy, antioxidant
Alpha-Tocopherol (Vitamin E) — botanical close-up

Health Benefits

**Lipid Peroxidation Prevention**
Alpha-tocopherol intercepts lipid peroxyl radicals via HAT, donating a hydrogen atom and terminating the chain reaction of oxidative damage within cell membranes; this protects polyunsaturated fatty acids (PUFAs) critical to cellular integrity and membrane fluidity.
**Photooxidative Stress Mitigation**: Within D
tertiolecta itself, alpha-tocopherol acts synergistically with xanthophyll cycle pigments (including violaxanthin) to quench singlet oxygen and dissipate excess photonic energy, preventing chloroplast damage under high light conditions.
**Cellular Membrane Protection**
As a fat-soluble antioxidant embedded in lipid bilayers, alpha-tocopherol scavenges ROS proximal to membrane phospholipids, preserving structural integrity of mitochondrial and plasma membranes in mammalian cells.
**Potential Antiproliferative Context**: D
tertiolecta co-produces violaxanthin, which demonstrated antiproliferative activity against cancer cell lines in vitro (Pasquet et al., 2011); while distinct from alpha-tocopherol, this co-occurrence suggests a bioactivity-rich extract profile that may complement antioxidant functions.
**Support for Endogenous Antioxidant Networks**
Alpha-tocopherol interacts with ascorbic acid (vitamin C) and glutathione in regenerative redox cycles; oxidized tocopheroxyl radicals can be reduced back to active alpha-tocopherol by ascorbate, extending its antioxidant capacity.
**Mitochondrial Oxidative Protection**
Tocopherols localize preferentially to mitochondrial inner membranes, where they reduce electron transport chain-derived superoxide and hydroxyl radical damage, a mechanism relevant to anti-aging research and preservation of bioenergetic function.
**Biotechnological Antioxidant Source Potential**
Microalgal-derived alpha-tocopherol from D. tertiolecta offers a non-animal, scalable source with concentrations (up to 1.90 mg/g DW) competitive with or exceeding some conventional food sources, providing a structurally natural RRR-alpha-tocopherol stereoisomer rather than synthetic all-racemic forms.

Origin & History

Alpha-Tocopherol / Vitamin E growing in coastal — natural habitat
Natural habitat

Dunaliella tertiolecta is a unicellular, halotolerant green microalga found in marine and brackish coastal environments worldwide, thriving in high-salinity conditions ranging from 0.5 M to 4.0 M NaCl. It is cultivated in controlled photobioreactor or open pond systems supplemented with nitrogen- and phosphorus-rich nutrient media, with alpha-tocopherol accumulation peaking in high-density, light-limited cultures during the linear and stationary growth phases. Unlike terrestrial plant sources of vitamin E such as wheat germ or sunflower seeds, D. tertiolecta represents a purely aquatic, photosynthetic biotechnological production platform with no historical agricultural or traditional cultivation background.

Dunaliella tertiolecta carries no documented history of use in traditional medicine, ethnobotany, or any indigenous food culture; it was not identified or characterized as a distinct species until the 20th century and exists exclusively as a subject of modern marine biotechnology. Scientific investigation of D. tertiolecta for tocopherol production emerged prominently in the early 2000s as part of broader interest in microalgae as sustainable sources of high-value bioactives including carotenoids, lipids, and antioxidants. Unlike its genus relative Dunaliella salina—which has a modest historical context as a natural beta-carotene source and is cultivated commercially in Australian saline lakes—D. tertiolecta has remained entirely in the domain of laboratory and pilot-scale biotechnological research. The compound alpha-tocopherol itself was first isolated in 1936 from wheat germ oil by Evans, Emerson, and Emerson, and its name derives from the Greek 'tokos' (childbirth) and 'phero' (to bear), reflecting early observations of its role in reproductive health in animal models.Traditional Medicine

Scientific Research

Research on alpha-tocopherol from Dunaliella tertiolecta specifically is confined entirely to biotechnological production studies; no human clinical trials, animal efficacy studies, or pharmacokinetic investigations using D. tertiolecta-derived alpha-tocopherol as a supplement have been published as of the current literature search. The evidence base for D. tertiolecta as a tocopherol source consists of batch cultivation experiments characterizing the relationship between light intensity, cell density, nutrient availability, and alpha-tocopherol accumulation, with reported yields up to 1.90 mg/g DW across Dunaliella species. In vitro antiproliferative activity of co-produced violaxanthin from D. tertiolecta was reported by Pasquet et al. (2011), but this relates to a distinct compound and provides no direct clinical evidence for alpha-tocopherol supplementation. The broader vitamin E clinical literature—derived from terrestrial plant sources—is extensive but distinct, and efficacy data from those trials cannot be reliably extrapolated to this specific microalgal production form without dedicated bioequivalence and bioavailability studies.

Preparation & Dosage

Alpha-Tocopherol / Vitamin E ground into fine powder — pairs with Alpha-tocopherol exhibits well-characterized synergy with ascorbic acid (vitamin C), which regenerates the active tocopherol form from the tocopheroxyl radical via single electron reduction, effectively recycling antioxidant capacity and extending the functional lifespan of membrane-bound vitamin E; this alpha-tocopherol/ascorbate regenerative cycle is one of the most mechanistically established antioxidant
Traditional preparation
**Biotechnological Extraction (Research Form)**
Alpha-tocopherol is extracted from D. tertiolecta biomass post-cultivation using lipid extraction solvents (e.g., hexane, chloroform-methanol mixtures); it co-occurs with beta-carotene, violaxanthin, and phytosterols and requires HPLC or saponification-based separation for purification.
**Optimal Cultivation Conditions**
90 mg/g DW in Dunaliella species) is achieved in high-density, light-limited batch cultures during the linear or stationary growth phase with supplemental nutrients; this is a production parameter, not a dosage recommendation
Maximum alpha-tocopherol content (approximately 1..
**No Established Supplement Form**
As of current literature, no standardized commercial supplement form (capsule, softgel, powder, oil) of D. tertiolecta-derived alpha-tocopherol has been validated or marketed; it remains a research-stage ingredient.
**General Vitamin E Reference Doses (from non-algal sources)**
15 mg/day for adults; tolerable upper intake level (UL) is 1,000 mg/day from supplemental sources per Institute of Medicine guidelines
Recommended Dietary Allowance (RDA) for alpha-tocopherol is .
**Bioavailability Note**
Natural RRR-alpha-tocopherol (as would be produced by D. tertiolecta) demonstrates approximately twice the bioavailability of synthetic all-racemic alpha-tocopherol (dl-alpha-tocopherol) in human tissues; microalgal forms are presumed to be in the natural stereoisomeric configuration but this has not been confirmed for D. tertiolecta specifically.
**Timing**
Fat-soluble vitamin E from any source is best absorbed when taken with a meal containing dietary fat to facilitate micellar solubilization and chylomicron-mediated lymphatic absorption; this principle would apply to any future D. tertiolecta-derived supplement.

Nutritional Profile

Alpha-tocopherol content in Dunaliella tertiolecta reaches up to approximately 1.90 mg per gram dry weight under optimized cultivation conditions, placing it within the reported range of 0.01–6.32 mg/g DW for microalgal tocopherols generally. D. tertiolecta biomass also contains beta-carotene (a pro-vitamin A carotenoid), violaxanthin, xanthophylls, phytosterols, and a complement of polyunsaturated fatty acids including omega-3 and omega-6 series lipids, though precise quantitative profiles are not uniformly reported across cultivation conditions. The lipid fraction from which tocopherol is extracted represents a concentrated source of fat-soluble antioxidants; bioavailability of alpha-tocopherol from microalgal matrices is presumed to benefit from co-occurring lipids that facilitate micellar absorption, but no in vivo bioavailability studies specific to D. tertiolecta have been conducted. As a microalgal source, it contains no animal-derived compounds and offers a vegan-compatible, RRR-stereoisomeric form of alpha-tocopherol, though macro- and micronutrient contributions from supplemental doses of an extracted compound would be negligible.

How It Works

Mechanism of Action

Alpha-tocopherol functions primarily through two physicochemical antioxidant pathways: hydrogen atom transfer (HAT), in which the phenolic O-H bond of the chroman ring donates a hydrogen atom to peroxyl radicals (LOO•) to form a stable tocopheroxyl radical (TO•), and single electron transfer (SET), where it reduces radical species by direct electron donation. The tocopheroxyl radical produced is relatively stable due to resonance delocalization across the chromanol ring and does not propagate lipid peroxidation chain reactions, effectively terminating oxidative cascades in lipid bilayers. At the molecular level, alpha-tocopherol also modulates protein kinase C (PKC) activity independently of its antioxidant capacity—direct inhibition of PKC-alpha and PKC-beta isoforms has been documented, with downstream effects on cell signaling pathways governing inflammation and cell proliferation. Additionally, alpha-tocopherol influences gene expression of scavenger receptors (e.g., CD36) and connective tissue synthesis-related genes, and it interacts with tocopherol-associated proteins (TAPs) and alpha-tocopherol transfer protein (alpha-TTP) in the liver for preferential retention and systemic distribution of the RRR-stereoisomer.

Clinical Evidence

No clinical trials have evaluated alpha-tocopherol derived specifically from Dunaliella tertiolecta in human subjects, rendering direct clinical evidence entirely absent for this source. The existing research is restricted to laboratory-scale photobioreactor cultivation studies optimizing yield parameters, with no documented phase I, II, or III trials assessing safety, pharmacokinetics, efficacy, or tolerability. In vitro work by Pasquet et al. (2011) examined the antiproliferative potential of violaxanthin co-extracted from D. tertiolecta, not alpha-tocopherol itself, and no effect sizes or sample sizes applicable to supplemental use were reported. Confidence in any clinical recommendation for D. tertiolecta-derived alpha-tocopherol as an anti-aging or antioxidant supplement remains very low, and its use would currently rest entirely on the general clinical evidence base for alpha-tocopherol from conventional sources rather than this specific algal origin.

Safety & Interactions

No safety data, toxicological studies, adverse event reports, or drug interaction assessments exist specifically for alpha-tocopherol derived from Dunaliella tertiolecta in human or animal subjects, making it impossible to establish a source-specific safety profile at this time. Extrapolating from the general alpha-tocopherol safety literature: supplemental vitamin E at doses above 400 IU/day (approximately 268 mg RRR-alpha-tocopherol) has been associated with a modest increase in all-cause mortality in some meta-analyses (Miller et al., JAMA, 2005), and doses exceeding the tolerable upper limit of 1,000 mg/day significantly increase hemorrhagic risk due to antagonism of vitamin K-dependent coagulation factors. Alpha-tocopherol interacts clinically with anticoagulants (warfarin, heparin) by potentiating anticoagulant effects and increasing bleeding risk; it may also interfere with the absorption of other fat-soluble vitamins (A, D, K) at high doses and can reduce the efficacy of some chemotherapeutic agents by attenuating oxidative cytotoxicity. Microalgal biomass sources like D. tertiolecta may introduce additional safety considerations related to heavy metal accumulation, marine contaminants, or allergenic proteins that have not been characterized; use during pregnancy or lactation cannot be evaluated for this source without dedicated safety studies.

Synergy Stack

Hermetica Formulation Heuristic

Also Known As

Dunaliella tertiolectaα-tocopherolRRR-alpha-tocopherolVitamin Eα-T

Frequently Asked Questions

What is alpha-tocopherol from Dunaliella tertiolecta and how is it different from regular vitamin E?
Alpha-tocopherol from Dunaliella tertiolecta is vitamin E biosynthesized by a marine green microalga rather than extracted from conventional plant sources like wheat germ or sunflower oil. It is presumed to exist in the natural RRR-stereoisomeric configuration, which has approximately twice the biological activity of synthetic all-racemic vitamin E, though this has not been formally confirmed in bioavailability studies for this specific algal source.
Are there any clinical trials on Dunaliella tertiolecta vitamin E for anti-aging?
No clinical trials have been conducted on alpha-tocopherol specifically derived from Dunaliella tertiolecta; all published research focuses on optimizing its biotechnological production in photobioreactor systems rather than human health outcomes. Any anti-aging applications would currently rely on extrapolation from the broader vitamin E clinical literature, which itself shows mixed results across large randomized controlled trials.
How much vitamin E does Dunaliella tertiolecta produce?
Under optimized high-density, light-limited batch cultivation conditions, Dunaliella species including D. tertiolecta can accumulate alpha-tocopherol at concentrations reaching approximately 1.90 mg per gram of dry biomass weight. Production is enhanced during the linear and stationary growth phases when nutrients are supplemented, and yield is sensitive to light intensity, cell density, and nutrient availability.
Is Dunaliella tertiolecta vitamin E safe to supplement?
No dedicated safety, toxicology, or drug interaction studies have been performed on D. tertiolecta-derived alpha-tocopherol in humans or animals, making it impossible to confirm its safety as a supplement at this time. General alpha-tocopherol supplementation is considered safe at doses up to 1,000 mg/day (the tolerable upper limit), but high-dose use increases bleeding risk, particularly in individuals taking anticoagulant medications such as warfarin.
What other bioactive compounds does Dunaliella tertiolecta contain besides vitamin E?
Beyond alpha-tocopherol, D. tertiolecta produces beta-carotene (pro-vitamin A), violaxanthin (a xanthophyll carotenoid with demonstrated antiproliferative activity in vitro per Pasquet et al., 2011), other xanthophylls, phytosterols, and a range of polyunsaturated fatty acids. This co-occurrence of multiple fat-soluble antioxidants and bioactives makes D. tertiolecta an attractive candidate for full-spectrum marine microalgal extract development, though each compound requires independent clinical evaluation.
How does alpha-tocopherol from Dunaliella tertiolecta protect cell membranes at the molecular level?
Alpha-tocopherol from Dunaliella tertiolecta prevents lipid peroxidation by intercepting lipid peroxyl radicals through hydrogen atom transfer (HAT), which terminates the chain reaction of oxidative damage within cell membranes. This protection is especially critical for polyunsaturated fatty acids (PUFAs) that are essential for maintaining cellular integrity and membrane fluidity. By halting radical-induced damage before it spreads, this form of vitamin E helps preserve the structural and functional properties of cell membranes throughout the body.
What makes Dunaliella tertiolecta a preferred source of alpha-tocopherol compared to synthetic vitamin E supplements?
Dunaliella tertiolecta is a natural microalgae source that produces alpha-tocopherol in its native biological context, where it also produces complementary bioactive compounds that may enhance absorption and synergistic antioxidant effects. Unlike synthetic alpha-tocopherol isolates, the algae-derived form comes with its natural lipid matrix and associated carotenoids and polysaccharides, which may improve bioavailability and cellular utilization. The natural production process preserves the vitamin E in its most biologically active configuration within a living organism's metabolic system.
Can alpha-tocopherol from Dunaliella tertiolecta help protect against photooxidative stress and UV-related cellular damage?
Yes, alpha-tocopherol from Dunaliella tertiolecta is particularly effective against photooxidative stress because the algae itself produces this compound to protect against light-induced oxidative damage in its natural aquatic environment. When consumed, this vitamin E can help neutralize free radicals generated by UV exposure and other light-driven oxidative processes in human skin and tissues. This makes it especially relevant for individuals seeking support against environmental oxidative stressors, including sun exposure and pollution.

Explore the Full Encyclopedia

7,400+ ingredients researched, verified, and formulated for optimal synergy.

Browse Ingredients
These statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.